September 2023
1. VASWANI PPM, Onozawa M, Hasegawa Y, Ohigashi H, et al
   Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease.
   Bone Marrow Transplant. 2023 Sep 5. doi: 10.1038/s41409-023-02103.
   

   >> Share

   
   May 2023
2. GRECO R, Hoogenboom JD, Bonneville EF, Anagnostopoulos A, et al
   Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party.
   Bone Marrow Transplant. 2023;58:603-606.
   

   >> Share

   
   January 2023
3. SAVA M, Battig V, Gerull S, Passweg JR, et al
   Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates.
   Bone Marrow Transplant. 2023;58:115-118.
   

   >> Share

   
   September 2022
4. DE MOOIJ CEM, van der Velden WJFM, de Haan AFJ, Fazel S, et al
   Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy.
   Bone Marrow Transplant. 2022;57:1373-1381.
   

   >> Share

   
   April 2022
5. SCHROEDER MA, Hari PN, Blithe A, Paranagama D, et al
   Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program.
   Bone Marrow Transplant. 2022 Apr 18. pii: 10.1038/s41409-022-01673.
   

   >> Share

   
   July 2021
6. TAKAGI S, Ogura S, Araoka H, Uchida N, et al
   The impact of graft cell source on bloodstream infection in the first 100 days after allogeneic hematopoietic cell transplantation.
   Bone Marrow Transplant. 2021;56:1625-1634.
   

   >> Share

   
   April 2021
7. INOUE Y, Okinaka K, Fuji S, Inamoto Y, et al
   Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
   Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01291.
   

   >> Share

   
   January 2021
8. CESARO S, Tridello G, Knelange NS, Blijlevens N, et al
   Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.
   Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01212.
   

   >> Share

   
   September 2020
9. DI CRISTANZIANO V, Meyer-Schwickerath C, Eberhardt KA, Rybniker J, et al
   Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia.
   Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01059.
   

   >> Share

   
   September 2019
10. PUERTA-ALCALDE P, Cardozo C, Marco F, Suarez-Lledo M, et al
    Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0701.
    

    >> Share

    
    May 2019
11. KAITO S, Sekiya N, Najima Y, Suzuki T, et al
    Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 29. pii: 10.1038/s41409-019-0541.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share